J9311 Injection rituximab, hyaluronidase
J-Codes
Also known as: rituximab hyaluronidase, Rituxan subcutaneous
Injection of rituximab combined with hyaluronidase, an anti-CD20 monoclonal antibody with enhanced subcutaneous delivery. B-cell depleting agent.
Clinical Context
Subcutaneous formulation of rituximab for chronic lymphocytic leukemia, follicular lymphoma, and diffuse large B-cell lymphoma.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.